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Background: Treatment requirements in hepatolithiasis may vary and may involve a multidisciplinary
approach. Surgical resection has been proposed as a definitive treatment.
Objectives: This study aimed to evaluate the clinical results of anatomic liver resection among Chilean
patients with hepatolithiasis.
Methods: An historical cohort study was conducted. Patients who underwent hepatectomy as a defini-
tive treatment for hepatolithiasis from January 1990 to December 2010 were included. Patients with a
preoperative diagnosis of cholangiocarcinoma were excluded. Preoperative, operative and postoperative
variables were evaluated.
Results: A total of 52 patients underwent hepatectomy for hepatolithiasis. The mean  standard
deviation patient age was 49.8  11.8 years (range: 24–78 years); 65.4% of study subjects were female.
A total of 75.0% of subjects had a history of previous cholecystectomy. The main presenting symptom
was abdominal pain (82.7%). Hepatic involvement was noted in the left lobe in 57.7%, the right lobe in
34.6% and bilaterally in 7.7% of subjects. The rate of postoperative clearance of the biliary tree was
90.4%. Postoperative morbidity was 30.8% and there were no postoperative deaths. Three patients had
recurrence of hepatolithiasis, which was associated with Caroli's disease in two of them. Overall 5-year
survival was 94.5%.
Conclusions: Anatomic liver resection is an effective treatment in selected patients with hepatolithiasis
and is associated with low morbidity and no mortality. At longterm follow-up, anatomic hepatectomy in
these patients was associated with a lower rate of recurrence.
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Introduction
Hepatolithiasis has been defined as the occurrence of stones in any
intrahepatic bile duct proximal to the confluence of the right and
left hepatic ducts, irrespective of the presence of stones in the
main bile duct or the gallbladder.1 It is prevalent in Japan and
Southeast Asia2 and uncommon in Western countries.3,4
Hepatolithiasis is now more commonly detected with the
regular use of diagnostic imaging methods, of which the most
precise is cholangiographic assessment.5
Among patients in occidental countries, intrahepatic stones
usually occur secondary to bile stasis resulting from an extrahe-
patic factor (such as common bile duct stones, or postoperative or
inflammatory strictures of bile ducts), in congenital diseases (such
as Caroli’s disease), and in relation to the tendencies of some
ethnic groups towards lithogenic bile.6–8
Treatment options are diverse. The therapeutic purpose is to
obtain complete clearance of the stone and to avoid recurrent
episodes of cholangitis and subsequent hepatic fibrosis and sec-
ondary cholangiocarcinoma.1 Recently, non-surgical procedures,
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such as percutaneous transhepatic or peroral cholangioscopic
lithotripsy, have been applied to treat hepatolithiasis, but these
non-surgical procedures are associated with recurrence rates of
30–60%.9–11
Alternatively, liver resection has been proposed as a definitive
treatment for segmental hepatolithiasis because it treats not only
the stones, but also strictures and atrophic and inflammatory
changes.12
The aim of this study was to assess the factors associated with
hepatolithiasis in one centre and to evaluate the clinical results of
its treatment by anatomic liver resection.
Materials and methods
All patients presenting from January 1990 to December 2010 at
the Pontifical Catholic University of Chile Hospital were included
in this study. Hepatolithiasis was defined as the presence of stones
in the intrahepatic bile duct proximal to the right and left hepatic
duct confluence. Hepatectomy involved any procedure in which
excision of a part of the liver was performed using anatomic
techniques according to Couinaud’s segmentation and Brisbane
2000 terminology.13 Recurrence was deemed to have occurred
when clinical and imaging evidence of new lithiasis was detected
in the intrahepatic biliary duct above the biliary confluence.
Patients who were not candidates for hepatectomy and those
with a preoperative diagnosis of cholangiocarcinoma were
excluded from analysis.
Registered data
Demographic data as well as data on risk factors for hepa-
tolithiasis, comorbidities, previous surgical therapies, clinical
presentation, laboratory and imaging tests, perioperative data,
postoperative morbidity, mortality and postoperative stone recur-
rence were recorded for all subjects. The extent of disease was
assessed by imaging studies, including abdominal ultrasound
(US), computed tomography (CT) and/or magnetic resonance
cholangiopancreatography (MRCP). Some patients also under-
went endoscopic retrograde cholangiopancreatography (ERCP)
or percutaneous transhepatic cholangiography (PTC).Amultidis-
ciplinary team defined the type of liver resection based on
imaging findings.
Clinical results and patient outcomes were classified in short-
and longterm categories. Short-term results included postopera-
tive morbidity (any complication occurring within 30 days of
surgery). Longterm results included any morbidity or sequel
detected during follow-up (any complication occurring >30 days
after surgery), the rate of recurrence of stones and longterm
survival.
Procedural details
Hepatectomy was considered to be indicated in all patients with
symptomatic hepatolithiasis with hepatic or intrahepatic duct
stenosis, or with recurrent pyogenic cholangitis and atrophy of
the affected segments, with or without liver abscesses. An ana-
tomic resection (with or without the Pringle manoeuvre) using
an open or laparoscopic approach was performed for all seg-
ments affected by biliary stenosis and the affected bile duct
drainage area. Hepaticojejunostomy was performed in patients
with common bile duct stenosis and in those considered to be at
high risk for recurrence. At each exploration of the common bile
duct, routine cholangiography, with or without choledochoscopy,
was performed to ensure clearing of the biliary system.When the
biliary tract was not explored, cholangiography was achieved
through the cystic duct and US was performed to detect residual
stones. Drains were used routinely and removed postoperatively
if there was no evidence of bile leakage or bleeding between post-
operative days 2 and 5.
Postoperative management
Routine nasogastric drainage was not employed. Re-feeding was
initiated 24 h after surgery if the patient showed signs of gas-
trointestinal transit resumption and had no nausea. Antibiotic
prophylaxis was used for 24 h perioperatively. Standard doses of
therapeutic antibiotics were used in patients with cholangitis or
liver abscess. Routine liver tests were monitored after surgery on
days 1, 3 and 5, and as required according to the patient’s clinical
status.
Follow-up
Recurrence screening was conducted using liver function tests.
Ultrasound or CT were performed every 6 months for the first
2 years postoperatively and then annually or when the patient had
symptoms of recurrence. To confirm the suspicion of recurrence,
endoscopic or percutaneous cholangiography was carried out;
from 2000 onwards MRCP was used.
Statistical analysis
Variables are presented using descriptive statistics with measures
of central tendency and dispersion. Chi-squared and Fisher’s tests
were used for univariate subgroup and categorical variable analy-
ses. Student’s t-test and analysis of variance (anova) were used
for continuous variables. A binary logistic regression model was
generated for multivariate analysis. The Kaplan–Meier method
was used for survival analysis. A P-value of <0.05 was considered
to indicate statistical significance. All analyses were performed
using spss Version 18.0 (SPSS, Inc., Chicago, IL, USA).
Report
This manuscript was developed according to the STROBE
(strengthening the reporting of observational studies in epidemi-
ology) criteria for the reporting of cohort studies.14
Results
From 1990 to 2010, a total of 52 patients underwent anatomic
liver resection for treatment of hepatolithiasis. Twenty-six of these
operations (50.0%) were performed between 2004 and 2010.
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The mean  standard deviation (SD) age of patients was 49.8
 11.8 years (range: 24–78 years). Overall, 34 (65.4%) patients
were female, 39 (75.0%) had a prior history of cholecystectomy
and 20 (38.5%) had associated comorbidities (Table 1). The main
presenting symptom was abdominal pain. Acute cholangitis was
diagnosed in 18 (34.6%) patients (Table 2).
Diagnoses were obtained through US in 40 (76.9%) patients.
Computed tomography was performed in 26 (50.0%) patients.
Twenty-eight (53.8%) patients had ERCP and 16 of these under-
went papillotomy. Thirty (57.7%) patients underwent MRCP;
after 2000, this diagnostic modality was used in all but one patient.
Findings on MRCP indicated the presence of bile duct dilatation
in 25 patients, associated choledocholithiasis in eight, liver abscess
in three, stenosis of the intrahepatic bile duct in 27 patients, and
liver segment atrophy in one patient.
Hepatic involvement was noted in the left lobe in 30 patients
(57.7%), the right lobe in 18 (34.6%) and bilaterally in four
(7.7%) patients.
Development of hepatolithiasis after cholecystectomy
Thirty-nine (75.0%) patients had a prior history of cholecystec-
tomy. The mean period between cholecystectomy and the presen-
tation of hepatolithiasis was 17.8  10 years. No statistically
significant differences emerged when this period was analysed
according to which of the hepatic lobes were compromised.
Patients with right hepatic involvement (n = 17/18, 94.4%) were
significantly more likely to have a history of previous cholecystec-
tomy compared with those with left (n = 19/30, 63.3%) or bilateral
(n = 2/4, 50.0%) liver involvement (P < 0.05) (Table 3).
Caroli's disease
Evidence of Caroli’s disease was significantly more frequent in
surgical biopsy specimens of patients with left (n = 15/30, 50.0%)
or bilateral (n = 3/4, 75.0%) liver involvement than in specimens
of patients with right lobe involvement (n = 3/18, 16.7%) (P <
0.05). Of 17 patients with prior cholecystectomy who developed
hepatolithiasis in the right liver, only two had Caroli’s disease.
Multivariate analysis considering the presence of Caroli’s disease,
sex, age and previous cholecystectomy showed that the latter was
an independent risk factor for the development of right liver
hepatolithiasis (odds ratio = 6, 95% confidence interval 1.2–30.5;
P < 0.05) compared with left or bilateral hepatolithiasis (Table 3).
Surgical treatment
Themost frequent procedure was left lateral sectionectomy, which
was conducted in 42.3% of patients, three of whom underwent a
laparoscopic procedure. This was followed by right posterior sec-
tionectomy and left hepatectomy, conducted in 17.5% and 15.4%
of patients, respectively (Table 4).
Intraoperative US was performed for anatomic delineation in
32 (61.5%) patients. This rate increased to 78.1% from the year
2000.
Cholecystectomy was performed as an additional surgical pro-
cedure in 13 (25.0%) patients, choledochostomy in 16 (30.8%)
patients (13 patients prior to 2000) and hepaticojejunostomy in
three (5.8%) patients. Themean SD operative time was 229.7
84.0 min (range: 110–450 min).Mean SD intraoperative bleed-
ing amounted to 437  209 ml (range: 100–2000 ml). Hepatic
pedicle clamping (Pringle manoeuvre) was performed in 48.1% of
patients, with a mean clamping time of 32.0  14.5 min (range:
10–100 min).
Short-term results
The mean hospital stay was 11.1  8.8 days (range: 3–55 days).
Complete clearance of the biliary system was achieved in 47
(90.4%) patients. Early complications occurred in 16 (30.8%)
patients (Table 5), nine of whom had biliary complications. There
were no significant differences in the incidence of biliary compli-
cations according to type of surgery or segment affected. Three of
the five patients with bile leakage had Caroli’s disease that was
confirmed by histology. Three patients with bile leakage were
treated with drainage and the leakage resolved within 30 days of
surgery. Of the four patients with residual stones, two had post-
operative cholangitis and were treated with ERCP, and the other
two were treated percutaneously with choledochal drainage. The
Table 1 History of bile pathology or biliary surgery in the present
series (n = 52)
Bile pathology or biliary
surgery
n %
Patients with one or more record 42 80.8
Cholecystectomy 39 75.0
Choledocholithiasis 10 19.2
Caroli's disease 8 15.4
Acute biliary pancreatitis 2 3.8
Biliary bypass 1 3.8
Biliary resection 1 3.8
Table 2 Clinical presentation in the present series (n = 52)
Clinical presentation n %
Abdominal pain 43 82.7
Cholangitis 18 34.6
Jaundice 17 32.7
Fever 14 26.9
Choluria 11 21.2
Pruritus 3 5.8
Pancreatitis 3 5.8
Nausea 2 3.8
Acholia 2 3.8
Fatigue 2 3.8
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final rate of clearance of the biliary tree was 98.1%. There was no
postoperative liver failure and no inpatient mortality (Table 5).
Surgical specimen evaluation
(histopathological study)
Biopsy results showed that 21 (40.4%) patients had Caroli’s
disease. Biopsy findings also showed that 46 (88.4%) patients
had bile duct dilatation and periductal fibrosis, 21 (40.4%) had
chronic cholangiohepatitis, and nine (17.3%) had purulent cho-
langitis. Liver atrophy was found in two patients, micronodular
cirrhosis in another two patients, and intrahepatic bile duct
tubular adenocarcinoma in one.
Longterm results
The median follow-up was 63.7 months (range: 3–274 months).
Late complications occurred in 12 (23.1%) patients and were of
biliary origin in nine (17.3%) (Table 6). Biliary complications
included choledocholithiasis, hepatolithiasis and common hepatic
duct lithiasis in patients with biliodigestive anastomosis. One
patient had choledocholithiasis plus hepatolithiasis. All patients
with recurrence of lithiasis in the main biliary duct were success-
fully treated by endoscopic or percutaneous procedures.
Three patients developed recurrent hepatolithiasis. Two of
these patients have Caroli’s disease and are currently undergoing
treatment with ursodeoxycholic acid and have not developed
complications from their disease. The remaining patient with
recurrent hepatolithiasis developed stenosis of the biliodigestive
anastomosis, requiring multiple interventions. The patient is
currently listed for liver transplantation because of diffuse
hepatolithiasis.
In two of the five patients who developed bile leakage as an early
complication, fistulae remained unresolved for >30 days. One of
these patients had a common bile duct stenosis, required a bilio-
digestive anastomosis and thereafter had recurrent stones in the
common hepatic duct and required endoscopic balloon dilatation
with percutaneous extraction of bile duct stones. Some patients
had more than one complication (Table 6).
Overall survival at 5 years was 94.5%. Of the two patients who
died within 5 years of surgery, one had developed cholangiocar-
cinoma 6 months after surgery and the other demonstrated
chronic renal failure 53 months after surgery. Overall survival at
10 years was 90.5%; a third patient died of acute pneumonia
within 10 years of surgery. Three other patients died after the
10-year follow-up, all for reasons not attributable to surgery or
biliary stones.
Table 3 Relationship between prior cholecystectomy, Caroli's disease and liver lobe involvement
Liver lobe involvement P-value
Right liver Left liver Bilateral
Prior cholecystectomy 17 (94.4%) 19 (63.3%) 2 (50.0%) 0.035
Caroli's disease in biopsy specimen 3 (16.7%) 15 (50.0%) 3 (75.0%) 0.025
Table 4 Type of liver resection in hepatolithiasis (Brisbane
Terminology)13
Type of liver resection n %
Left lateral sectionectomy 22 42.3
Right posterior sectionectomy 9 17.5
Left hepatectomy 8 15.4
Right hepatectomy 6 11.5
Right anterior sectionectomy 2 3.9
Extended right hepatectomy 1 1.9
Extended left hepatectomy 1 1.9
Left lateral sectionectomy + segmentectomy VII 1 1.9
Right posterior sectionectomy + segmentectomy V 1 1.9
Segmentectomy VIII 1 1.9
Total 52 100
Table 5 Early complications in patients who underwent hepatec-
tomy for hepatolithiasis (n = 16/52)
Type of complication n %
Wound infection 2 12.5
Residual stones 4 25.0
Acute cholangitis 2 12.5
Intra-abdominal collection 3 18.8
Liver abscess 2 12.5
Atelectasis 3 18.8
Pleural effusion 2 12.5
Bile leakage 5 31.3
Acalculous obstructive jaundice 1 6.3
Hepatic infarction 1 6.3
Table 6 Late complications in patients who underwent hepatectomy
for hepatolithiasis (n = 12/52)
Type of complication n %
Choledocholithiasis 3 25.0
Recurrent hepatolithiasis 3 25.0
Remnant bile duct lithiasis 2 16.7
Biliodigestive anastomosis stenosis 2 16.7
Bile leakage for >30 days 2 16.7
Intestinal obstruction 1 8.3
Incisional hernia 1 8.3
Abdominal collection 1 8.3
Pulmonary embolism 1 8.3
Hepatic infarction 1 8.3
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Discussion
In the past 10 years, the introduction of new imaging technology
in clinical practice has improved the diagnosis of hepatolithiasis.
Magnetic resonance imaging (MRI) and MRCP are non-invasive
tests that not only allow the clear diagnosis of hepatolithiasis, but
also facilitate the complete evaluation of the biliary system and the
degree of liver atrophy. This allows for better planning of treat-
ment for patients and clarifies indications for surgery.7 In the
present series, US continued to play a leading role in the diagnosis
of hepatolithiasis, but since the advent of MRCP, almost all
patients have been evaluated using MRI or MRCP as the main
diagnostic tool.
There are many treatment modalities for intrahepatic stones.
The most frequently used are endoscopic and percutaneous treat-
ments, with or without lithotripsy, by choledochoscopy and
surgery (hepatectomy or biliary bypass). Currently, there is no
consensus on which treatment best achieves adequate clearing of
the biliary tree and lower rates of residual stones, recurrence,
morbidity and mortality. The main objectives in the management
of this disease are to extract all intra- and extrahepatic stones, and
to remove any bile duct stenosis, affected bile duct drainage areas
and all atrophic segments. The chronic inflammatory process that
causes stones in the intrahepatic bile ducts is a well-known risk
factor for cholangiocarcinoma and the only treatment to elimi-
nate this bile duct pathology is liver resection.15
In the present series, the rate of stone clearance at 30 days prior
to surgery was 91.4% and all failures occurred at an extrahepatic
level. After percutaneous or endoscopic treatment, the clearance
rate rose to 98.1% postoperatively. These results are comparable
with those in a series reported by Uenishi et al.,16 in which 86
patients underwent hepatectomy for hepatolithiasis, achieving an
initial clearance rate of 88%, which increased after postoperative
choledochoscopy with lithotripsy. These clearance rates are con-
siderably higher than those achieved by a single percutaneous
treatment (44%) or single endoscopic treatment (57%) in a com-
parative study by Cheon et al.17 Treatment with ERCP alone
reported clearance rates that did not exceed 70%.18,19 The devel-
opment of more effective lithotripsy techniques, such as laser and
percutaneous electrohydraulic lithotripsy, have resulted in bile
duct clearance rates of 73–96%, but recurrence rates are high.9,20–24
The present series recorded no postoperative mortality, but did
show high morbidity, most of which concerned infections. This
increased rate may reflect the high number of patients who under-
went surgery with recurrent cholangitis and/or medically treated
episodes of acute cholangitis. The high rate of bile leakage after
elective hepatectomy is probably associated with the substantial
proportion (40.4%) of patients with Caroli’s disease, as similar
associations have been previously reported.25–27
In the present study, the recurrence rate was 13.5% and the
median follow-up was 63.7 months. Recurrences occurred mainly
in the extrahepatic bile ducts and were successfully treated with
ERCP. The rate of recurrence in the intrahepatic bile ducts was
5.8%, which is lower than comparative rates reported in other
studies using similar treatment.12,28 The higher rates of recurrence
probably reflect the development of biliary stenosis, which occurs
in 42–96% of patients with hepatolithiasis and is the main factor
in recurrence. Consequently, when treatment does not involve
removing the stenotic bile duct, recurrence is likely to occur
relatively soon.9,29–32
In the present study, an analysis of causes associated with
hepatolithiasis revealed that 50.0% of patients showed evidence
of Caroli’s disease in biopsy specimens. Similar results have
been reported by other authors in occidental countries,19,33 where
patients have a different pathophysiology.34
The left liver lobe emerged as the most frequent location of
hepatolithiasis in the present series, which is consistent with find-
ings reported by other authors.1,6,7,35 This can be explained by the
acute angle taken by the left hepatic duct when it reaches the
confluence, which results in more bile stasis when associated with
stenosis of the biliary system. However, the frequency of left hepa-
tolithiasis in the present series (57.7%) was lower than those
reported by Chen et al.36 (77%) in a series of 103 patients and
Jiang et al.37 (72%) in 106 patients. This difference reflects the
higher frequency of right hepatolithiasis in the present series
(32.7%). This higher frequency of right side involvement, espe-
cially in the posterior segments, may be explained by the presence
of anatomic variations in which the posterior segment artery
comes from the common hepatic artery or is divided so that a
branch passes through the gallbladder fossa, which can be injured
during cholecystectomy, resulting in ischaemia of the bile ducts in
that area. It is the present authors’ belief that the history of pre-
vious cholecystectomy in patients with iatrogenic vascular injuries
during cholecystectomy is related to right side involvement;
however, further study is required to substantiate this effect. It is
noteworthy that the average period between cholecystectomy and
the diagnosis of hepatolithiasis was 18 years. Balandraud et al.38
found anatomic variations in 14 patients with right hepatolithi-
asis, whereby a cranial shift of the right sectorial ducts proximal to
the hepatic confluence, present in six of the patients, was an inde-
pendent risk factor for hepatolithiasis and explained the occur-
rence of bile stasis and formation of hepatolithiasis.
The surgical protocol used in the present institution favours
anatomic over non-anatomic liver resection as themain approach.
This is supported by studies that have shown the former to have
benefit in terms of reducing the incidence of residual lithiasis, bile
leakage and recurrence.37,39
In the present series, morbidity reached 30.8% and most com-
plications were mild and rapidly resolved; these results are com-
parable with the international standard.40 No postoperative liver
failure occurred in the present series, although two patients had
liver cirrhosis.
The treatment of patients with bilateral hepatolithiasis is con-
troversial and patients with bilateral disease show higher rates of
recurrence. Therapeutic approaches range from hepatectomy to
complex bilioenteric anastomosis using a subcutaneous loop to
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remove residual or recurrent lithiasis.41–43 In the present series,
only four patients had bilateral hepatolithiasis, three of whom
underwent hepatectomy for severe involvement in segments on
both sides. The remaining patient underwent a left lateral section-
ectomy in addition to the extraction of the contralateral lithiasis
by intraoperative choledochoscopy. To date, none of these patients
have demonstrated residual stones or recurrence.
The association between hepatolithiasis and cholangiocarci-
noma is well known; hepatolithiasis has been reported to occur in
2–10% of cholangiocarcinoma patients.15 Patients with a preop-
erative diagnosis of cholangiocarcinoma were excluded from the
present series. However, in one patient, an intraoperative inciden-
tal diagnosis was confirmed by frozen biopsy. The patient under-
went radical oncological surgery with lymph node dissection and
achieved survival of 6 months. None of the patients in the present
series developed cholangiocarcinoma during follow-up. However,
Chen et al.44 observed that 9% of patients with and 3% of those
without residual stones developed cholangiocarcinoma.
The prevention of hepatolithiasis and bile stasis at an early stage
avoids the end result of progressive liver failure and cirrhosis.
However, in patients with diffuse bilateral hepatolithiasis, disease
recurrence can lead to repeated episodes of cholangitis, liver
atrophy and biliary cirrhosis associated with portal hypertension
and liver failure. Liver transplantation has become the best treat-
ment option for patients with end-stage liver disease.45 Patients
with diffuse hepatolithiasis and secondary biliary cirrhosis should
consider liver transplantation, which eliminates the possibility of
developing cholangiocarcinoma, as an alternative treatment.
The present authors believe that hepatectomy is the best treat-
ment when hepatolithiasis is located in a segment or lobe associ-
ated with biliary stenosis or atrophy of a segment or liver lobe.
Hepatectomy should also be considered as the treatment of choice
when there is suspicion or certainty of cholangiocarcinoma.
Endoscopic or percutaneous treatment should be considered as a
first approach in patients with a poor performance status and in
patients with postoperative residual or recurrent lithiasis.
Conclusions
This study showed that anatomic hepatectomy is an effective and
safe procedure for hepatolithiasis associated with intrahepatic
biliary stenosis, liver abscess or liver atrophy, and that it has low
morbidity and no mortality. Longterm follow-up showed hepate-
ctomy in these patients to be associated with a low rate of
recurrence.
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